ONTEX Toolkit – Spread the Word

by Jazzmin Huber | Jan 31, 2023 | Clinical Trials, ONTEX, Resources and Support

Welcome to the ONTEX social media toolkit. We are delighted to have launched our new improved Osteosarcoma Now Trial EXplorer (ONTEX). Each osteosarcoma clinical trial has been summarised to give a clear picture of its aims, what it involves and who can take part. Its...

Introducing the Osteosarcoma Now Trial EXplorer (ONTEX)

by Jazzmin Huber | Jan 20, 2023 | Clinical Trials, Resources and Support

We are delighted to launch our new improved Osteosarcoma Now Trial EXplorer (ONTEX). ONTEX is an international database that aims to make clinical trial information available and accessible to all. Each osteosarcoma clinical trial has been summarised to give a clear...

CTOS Annual Meeting – The Highlights

by Jazzmin Huber | Dec 6, 2022 | Clinical Trials, Research

In November 2022 we attended the Connective Tissue Oncology Society (CTOS) meeting. This meeting brought together clinicians, researchers and patient advocates dedicated to improving outcomes in sarcoma. In this blog we highlight some of the talks with a focus on...

Fighting Osteosarcoma Through Research Together

by Jazzmin Huber | Oct 25, 2022 | Clinical Trials, Research

This October clinicians, researchers and patient advocates from across Europe came together for the first in-person FOSTER (Fighting OSteosarcoma Through European Research) meeting. The event was held over two days at the Gustave Roussy Cancer Research hospital in...

ICONIC: A Recruiting Osteosarcoma Trial

by Jazzmin Huber | Aug 16, 2022 | Clinical Trials, Research

In the 1970s the treatment for osteosarcoma (OS) was completely transformed by chemotherapy. Suddenly a cancer that previously had very few options was curable. However, since then there have been few changes to the treatment. Not only can the drugs cause long-term...

What We Can Learn from Recent Osteosarcoma Clinical Trials

by Jazzmin Huber | Aug 2, 2022 | Clinical Trials, Research

Two trials have recently been published looking at new treatments in osteosarcoma (OS). Although the results showed no or limited effect in OS, there is a lot that can be learned from these clinical trials. The results can help to shape future research and find new...